Which stocks are moving on Wednesday?
By Mill Chart
Last update: Apr 3, 2024
Let's take a look at the stocks that are in motion in today's session.
Today's top gainers
| Ticker | Change | Comment |
|---|---|---|
| UCAR | 10.0K% | In an impressive move, U POWER LTD's (NASDAQ:UCAR) shares recorded a 10.0K% increase, closing at $5.94 during Wednesday's session. In the last 3 months the share price dropped with 57.12%. |
| RENT | 2.0K% | RENT THE RUNWAY INC-A's (NASDAQ:RENT) shares rose 2.0K% to $5.88 during Wednesday's session. Shareholders saw the stock price going 29.98% lower in the past 3 months. |
| MDIA | 65.12% | MEDIACO HOLDING INC-CL A's (NASDAQ:MDIA) shares rose 65.12% to $1.42 during Wednesday's session. In the last month the share price increased with 71.66%. |
| KTRA | 50.9% | In an impressive move, KINTARA THERAPEUTICS INC's (NASDAQ:KTRA) shares recorded a 50.9% increase, closing at $0.15 during Wednesday's session. Earlier today the company had a press release: KTRA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Kintara Therapeutics, Inc. Is Fair to Shareholders. |
| AISPW | 43.75% | Positive market sentiment drove AIRSHIP AI HOLDINGS INC-CW28's (NASDAQ:AISPW) stock price up by 43.75% to $0.92 during Wednesday's session. Shareholders saw the stock price going 540.0% higher in the past month. |
| ACB | 41.42% | AURORA CANNABIS INC's (NASDAQ:ACB) shares rose 41.42% to $7.09 during Wednesday's session. The stock is trading 65.18% higher than a month ago. |
| YTEN | 40.68% | YIELD10 BIOSCIENCE INC's (NASDAQ:YTEN) shares rose 40.68% to $0.31. Shareholders saw the stock price going 30.16% lower is the past 6 months. |
| VNDA | 32.48% | In an impressive move, VANDA PHARMACEUTICALS INC's (NASDAQ:VNDA) shares recorded a 32.48% increase, closing at $5.18 during Wednesday's session. In the last year the stock lost 43.09%. |
| MSAI | 30.96% | Positive market sentiment drove MULTISENSOR AI HOLDINGS INC's (NASDAQ:MSAI) stock price up by 30.96% to $2.95 during Wednesday's session. The stock is trading 21.88% lower than a month ago. |
| ASXC | 28.35% | ASENSUS SURGICAL INC (NYSEARCA:ASXC) witnessed a notable 28.35% uptick in its shares, reaching $0.27 during Wednesday's session. The stock is trading 31.14% lower than a month ago. |
For the full top gainers list go to our top gainers page.
Today's top losers
| Ticker | Change | Comment |
|---|---|---|
| CASA | -80.43% | CASA SYSTEMS INC (NASDAQ:CASA) encountered a 80.43% decrease in its shares, reaching $0.05 during Wednesday's session. A press release (Casa Systems Initiates Court-Supervised Chapter 11 Sale Process for Businesses) was released earlier today. |
| VIEW | -45.45% | There was a downturn in VIEW INC's (NASDAQ:VIEW) shares, as they experienced a 45.45% decline, closing at $0.6 during Wednesday's session. A press release (View, Inc. Reaches Agreement with Cantor Fitzgerald and RXR to Become a Private Company) was released yesterday. |
| JZXN | -43.73% | During Wednesday's session, JIUZI HOLDINGS INC's (NASDAQ:JZXN) shares took a tumble, falling 43.73% to $2.11. In the last month the stock gained 205.0%. |
| SINT | -43.52% | There was a notable decline in SINTX TECHNOLOGIES INC's (NASDAQ:SINT) shares, as they dropped 43.52% to $0.02 during Wednesday's session. The stock is trading 69.84% lower than a month ago. |
| ANGH | -42.78% | ANGHAMI INC (NASDAQ:ANGH) encountered a 42.78% decrease in its shares, reaching $1.03 during Wednesday's session. The stock is trading 93.03% higher than a month ago. |
| TCON | -39.85% | TRACON PHARMACEUTICALS INC's (NASDAQ:TCON) stock price faced a 39.85% decline, reaching $0.25 during Wednesday's session. A press release (TRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent Data Monitoring Committee Recommendation to Continue the Trial as Planned) was released earlier today. |
| MTNB | -37.14% | MATINAS BIOPHARMA HOLDINGS I's (NYSEARCA:MTNB) stock price encountered a 37.14% decline, reaching $0.22 during Wednesday's session. In the last month the stock gained 30.06%. |
| FGEN | -31.5% | FIBROGEN INC's (NASDAQ:FGEN) shares fell 31.5% to $1.48. In the last 3 months the stock gained 188.0%. |
| VLCN | -21.18% | VOLCON INC's (NASDAQ:VLCN) stock price faced a 21.18% decline, reaching $0.34 during Wednesday's session. Shareholders saw the stock price going 58.71% lower in the past month. |
| ASST | -20.89% | ASSET ENTITIES INC-B's (NASDAQ:ASST) stock price faced a 20.89% decline, reaching $0.5 during Wednesday's session. The stock is trading 33.39% higher than 3 months ago. |
To see the full list of top losers you can use our top losers page.
FIBROGEN INC
NASDAQ:FGEN (5/2/2024, 11:19:09 AM)
1.185
+0.02 (+1.28%)
FGEN News
SAN FRANCISCO, April 29, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce first quarter 2024 financial results on Monday, May 6 after...
SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that clinical data from the dose escalation portion of...
a month ago - Market News VideoNotable Wednesday Option Activity: FGEN, PLCE, MDBa month ago - Market News VideoCommit To Buy FibroGen At $1, Earn 44.2% Annualized Using OptionsFG-3246 demonstrated efficacy in adenocarcinoma selected cohorts receiving biologically active doses of FG-3246 at ≥ 1.2 mg/kg in heavily pre-treated,...
SAN FRANCISCO, March 26, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Thane Wettig, Chief Executive Officer, will...
a month ago - InvestorPlace3 Nightmare Nasdaq Stocks Not Worth Holding Another DaySelling these three NASDAQ stocks might be the best option now, as they continue to show potential issues and continued weakness.
SAN FRANCISCO, March 11, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the appointment of Deyaa Adib, M.D., an executive leader...
2 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayIt's time to dive into the biggest pre-market stock movers as we check out all of the hottest news affecting shares on Tuesday morning!
2 months ago - Seeking AlphaAstraZeneca returns right to roxadustat to FibroGen (NASDAQ:FGEN)AstraZeneca returns rights to FibroGen for roxadustat, a drug used for treating anemia related to chronic kidney disease. Read more here.
• Topline data from two pivotal pamrevlumab pancreatic cancer trials anticipated in 2Q 2024 • Additional data from Phase 1 monotherapy study of FG-3246...
The FibroGen – AstraZeneca China Agreement for Roxadustat remains in place FibroGen to explore licensing opportunities for Roxadustat SAN FRANCISCO,...
